89bio Inc

NASDAQ:ETNB

9.08

+0.20 (+2.25%)

5:05:57 PM EDT: $9.10 +0.02 (+0.22%)

89bio Inc Stock, NASDAQ:ETNB

142 Sansome Street, 2nd floor, San Francisco, California 94104

United States of America

Phone: +1.415.432.9270

Number of Employees: 70

http://www.89bio.com

Description

89bio, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases. Its product pipeline includes pegozafermin, FGF21, NASH, and SHTG. The company was founded on January 18, 2018 and is headquartered in San Francisco, CA.